EF
HALO icon

Empowered Funds’s Halozyme HALO Stock Holding History

Empowered Funds’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.88M Sell
87,905
-296,633
-77% -$20.2M 0.04% 559
2026
Q1 		$24.9M Sell
384,538
-126,411
-25% -$8.91M 0.16% 125
2025
Q4 		$34.4M Buy
510,949
+39,825
+8% +$2.68M 0.58% 27
2025
Q3 		$34.6M Buy
471,124
+4,521
+1% +$300K 0.35% 37
2025
Q2 		$24.3M Buy
466,603
+454,771
+3,844% +$25.9M 0.27% 65
2025
Q1 		$755K Buy
+11,832
New +$687K 0.01% 1093
2023
Q2 		– Sell
-55,766
Closed -$2.13M – 1144
2023
Q1 		$2.13M Buy
+55,766
New +$2.62M 0.13% 200

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Empowered Funds's HALO Position: Q2 2026 in Review

Empowered Funds reduced its Halozyme (HALO) stake by 77% in Q2 2026, selling an estimated $20.2M and leaving 87,905 shares worth $6.88M. The position accounts for 0.04% of the portfolio, ranked #559.

Empowered Funds first reported a position in HALO in Q1 2023 and has held it in 7 quarters since. The position peaked at $34.6M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Empowered Funds held 87,905 shares of Halozyme worth $6.88M as of Q2 2026.
  • Empowered Funds sold 296,633 Halozyme shares in Q2 2026, an estimated $20.2M.
  • Halozyme made up 0.04% of Empowered Funds's portfolio in Q2 2026, its #559 holding.
  • Empowered Funds first reported a position in Halozyme in Q1 2023 and has held it in 7 quarters since.
  • Empowered Funds's Halozyme position peaked at $34.6M in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.